Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Covington represents private and public companies and venture investors in a broad range of industries, including life sciences, technology, fintech, cleantech and defense/national security.
We support our clients with a responsive dedicated team, a pragmatic cost-effective approach to problem solving, significant partner involvement, and deep industry and regulatory expertise.
Our practice spans the U.S., UK, Europe and Asia.
We view our relationship with each emerging company client as a long-term commitment. We invest the time it takes--upfront--to understand the client’s objectives, issues and relationships.
We advise early stage companies on a range of issues including: structuring the relationships among founders, intellectual property rights and strategy, employees and consultants, equity incentive plans, and initial funding.
As companies develop and expand, we provide strategic and legal advice, both domestic and international, in connection with Board and other governance issues, capital structure, strategic partnerships, distribution, licensing and other commercial arrangements, venture capital financings, IPOs and M&A transactions.
Our leading experts in areas such as data privacy, tech transactions, financial regulation and drug/device and health care regulation routinely advise clients on product development plans, compliance issues, innovative business models and commercial structures, and negotiating with large strategic partners.
Venture Capital Clients
We take a pragmatic, deal-oriented approach to venture capital transactions, focusing on critical due diligence and economic issues. We have significant experience and expertise in representing corporate venture capital groups, particularly in the life sciences and technology areas. We leverage our expertise in regulatory matters, collaboration/licensing transactions and M&A to advise our corporate venture clients on crafting milestones for tranched investments and structuring customized strategic rights arrangements, ranging from soft rights of first negotiation to fully-negotiated option agreements for the company itself or particular projects or IP. We also advise our corporate venture clients on fiduciary duties, conflicts of interest and confidentiality issues and obligations.
We have been involved in structuring and launching corporate venture capital initiatives for several of our corporate clients. We educate internal deal teams on venture capital practices and norms, and assist with the development of form documents.
Advised Cell Medica Ltd. in its £50 million series B funding round. Cell Medica Ltd. is a cellular immunotherapy company which develops, manufactures and markets patient-specific products for the treatment of cancer and infectious diseases.
Advised Prosper Marketplace in its last six rounds of financing, including its most recent $165M Series D financing.
Advised Prosper Marketplace, Inc. in its acquisition of American Healthcare Lending, LLC and merger with Prosper’s wholly owned subsidiary, Prosper Healthcare Lending, LLC.
Advised EverString Innovation Technology in a $12 million Series A financing.
Advised LanzaTech in a $60 million Series D financing led by Mitsui & Co., Ltd. and Guardians of New Zealand Superannuation Fund.
Advised Kit Check, Inc. in its $10.4 million Series A financing led by New Leaf Ventures and in its Series B financing led by Kaiser Permanente.
BiddingForGood, Inc., in its sale to FrontStream Holdings, Inc. a portfolio company of Arsenal Capital Partners.
Advised BiddingForGood in its recent Series E financing. BiddingForGood is the leading online auction platform for charitable entities.
Advised AstraZeneca as lead investor in a $20 million Series C funding round of PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company.
Advised Imperial Innovations and SROne on a £25 million Series C funding round in portfolio company PsiOxus Therapeutics which is developing innovative oncolytic immuno-oncology treatments for cancer.
Advised MedImmune Ventures as lead investor in the Series A Preferred Stock financing of G1 Therapeutics. G1 Therapeutics uses small molecule therapies that act by a novel mechanism to potentially prevent the hematological side effects of exposure to ionizing radiation and cancer chemotherapy, as well as other possible uses.
Advised VantagePoint Ventures Partners in connection with the Series A and Series B Preferred Stock financing of VionX Energy Corporation, which develops advance flow battery energy storage systems.
Advised Sanofi-Genzyme Bioventures in a Series C round for Immune Design Corp., a company developing innovative technologies to strengthen patient-specific immune responses to potentially fight cancer and other chronic diseases.
Advised Cedel International Investment, an international investment fund, in its investment in V-ME Media, Inc., the owners and operators of the V-ME Network, the fourth largest Spanish television network in the United States.
Represented Pearl Mobile DTV in establishing a nine-company venture to provide Mobile Digital Television services in the United States. Covington led the negotiations leading to the creation of the Pearl Mobile DTV venture, the negotiation of content license agreements, and public policy efforts before Congress and at the White House and the FCC.
Advised Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation in a £4 million funding round for Inivata, a clinical cancer genomics company spun out from Cancer Research UK.
Advised Tencent Holdings Limited in connection with its investment activities relating to public and private companies.
Advised Tencent Holdings Ltd. on its $50 million investment in Ontario-based KIKInteractive, Inc., a messenger application with more than 200 million registered users.
Advising a start-up blockchain company building an identity platform in connection with corporate, venture capital, privacy, and commercial licensing transactions.
February 28, 2017
NEW YORK—Tom Kuhn has joined Covington’s Mergers and Acquisitions practice, and will focus on media and technology transactions. He will be based in the firm’s New York office.
Mr. Kuhn is a seasoned M&A deal maker, with experience both as a lawyer and as a banker. He also advises on corporate governance matters and provides strategic counseling. He has ...
February 27, 2017
NEW YORK—Latinvex has named Covington partners Gabriel Mesa and Nicole Duclos among “Latin America’s Top 100 Lawyers” in 2017.
Mr. Mesa counsels corporations in joint ventures and private mergers and acquisitions in Latin America and other emerging markets, as well as in the United States. A client described Mr. Mesa as "an excellent lawyer,” noting that his ...
December 21, 2016
SHANGHAI—China Business Law Journal has named Covington partner Weishi Li to its “A-List” of the top 100 private practice lawyers in China. Ms. Li is one of two life sciences lawyers recognized by the magazine.
China Business Law Journal’s inaugural A-list is based on interviews of in-house counsel in China and around the world, as well as partners at Chinese ...
September 13, 2016, ABF Journal
Timothy Hester and Tom DeFilipps are quoted in an ABF Journal article regarding the arrival of DeFilipps to Covington. According to Hester, “Adding Tom to our Silicon Valley office is a major step forward in our plan for continued growth in California.”
DeFilipps says, “I am very pleased to join Covington’s growing California practice.” He continues, “I am ...
September 13, 2016, The Recorder
Tom DeFilipps and Doug Gibson are quoted by The Recorder in an article regarding DeFilipps’ recent move to Covington, where he will serve as chair of the West Coast corporate practice. According to DeFilipps, “Covington presented to me an opportunity to do something that sounded very interesting at this point in my career.” He continues, "I felt as though it was ...
September 13, 2016, Daily Journal
Tom DeFilipps and Doug Gibson are quoted in a Daily Journal article regarding DeFilipps’ move to Covington’s Silicon Valley office. Commenting on the draw to Covington DeFilipps says, “One of the more compelling aspects of the Covington platforms is the way it allows you to meld the strength of its regulatory practice in D.C. and non-U.S. jurisdictions, like ...
September 12, 2016
SILICON VALLEY—Tom DeFilipps has joined Covington as a partner in the Silicon Valley office and will serve as chair of the West Coast Corporate practice.
“Adding Tom to our Silicon Valley office is a major step forward in our plan for continued growth in California,” said Timothy Hester, Covington’s chair. “Tom has built a successful Northern California ...
September 12, 2016, Law360
Timothy Hester and Tom DeFilipps are quoted in a Law360 article regarding DeFilipps’ recent arrival. According to Hester, “Adding Tom to our Silicon Valley office is a major step forward in our plan for continued growth in California.” He continues, “Tom has built a successful Northern California corporate practice over many years and has a demonstrated track ...
January 29, 2016
NEW YORK — Latinvex has named Covington partner Gabriel Mesa among its “Latin America’s Top 100 Lawyers” for the third year in a row.
Resident in the firm’s New York office, Mr. Mesa counsels corporations in joint ventures and private mergers and acquisitions in Latin America and other emerging markets, as well as in the United States. His work spans venture ...
October 24, 2014
WASHINGTON, DC, October 24, 2014 — Springboard Enterprises honored Covington & Burling partner Ellen Corenswet at its annual Winners’ Circle awards dinner in New York City on October 21. Springboard is a national organization that fosters venture capital investments in women-led high growth companies. The Springboard Winners’ Circle awards are “presented to ...
February 15, 2013, Covington Advisory
January 7, 2013
NEW YORK, January 7, 2013 — Covington & Burling advised Illumina, Inc. on its announced acquisition of Verinata Health, Inc. for cash consideration of $350 million plus up to $100 million in milestone payments through 2015.
Upon completion of the acquisition, Illumina will have access to the Verinata’s verifi® prenatal test, the broadest non-invasive prenatal ...
SAN FRANCISCO, September 13, 2012 — Covington & Burling partner Bruce Deming has been named to the Daily Journal’s list of “Top 100 Lawyers” in California. The list recognizes “lawyers who moved the needle, had an impact on the legal industry, our state, the nation and the world,” said the publication’s editors, who considered more than 1,000 attorneys from ...
June 27, 2012
LONDON, 27 June, 2012 — For the second straight year, Euromoney Legal Media Group named Covington & Burling partner Lisa Peets “Best in Copyright” during its Europe Women in Business Law Awards.
Ms. Peets, whose practice encompasses legislative advocacy, trade and intellectual property enforcement, heads Covington’s European intellectual property group, and ...
June 13, 2012
NEW YORK, June 13, 2012 — Covington & Burling is strengthening its transactional capabilities in Latin America with the addition of Gabriel Mesa, a senior corporate lawyer with in-depth experience in the region.
Mr. Mesa joins the firm’s New York office as of counsel in the firm’s corporate practice where he is expected to advise corporations in joint ventures ...
May 17, 2012
LONDON, 17 May, 2012 — Euromoney Legal Media Group has named Covington & Burling partners Natalie Diep, Lisa Peets and Hilary Prescott as finalists for its second annual Europe Women in Business Law Awards.
Ms. Diep, who advises clients on a wide range of corporate finance issues including mergers and acquisitions, equity offerings, private placements and ...
January 29, 2009, Covington E-Alert
November 26, 2007
LONDON, November 26, 2007 - Covington & Burling LLP has advised SR One, the venture capital arm of GSK, on a Series B investment in Syntaxin Ltd, a biopharmaceutical company developing novel biologic drugs that control cell secretion. The round, which was co-led by SR One and Life Science Partners (LSP) with additional funds from one of Syntaxin’s existing ...
April 20, 2006
LONDON, April 20, 2006 - Covington & Burling has advised Baltic Oil Terminals (Baltic) on its £31.4 million placing and listing on the London Stock Exchange's AIM market. Baltic, a London-based company, has been established to invest in oil infrastructure projects and upstream activities in Russia and other countries in the former Soviet Union.Baltic will raise ...
October 3, 2005
WASHINGTON, D.C., October 3, 2005 - Covington & Burling announced the election of ten new partners, effective October 1. Stuart Stock, chair of the firm's management committee, commented: "These exceptional lawyers reflect the strength, excellence and diversity of the firm, and the continuing growth of our practices across the firm." Covington's newest partners ...
September 30, 2004
WASHINGTON, D.C., September 30, 2004 - Covington & Burling announced the election of five new partners, effective October 1. Stuart C. Stock, chair of the firm's management committee, commented: "These fine lawyers very much reflect the strength, excellence, and diversity of the firm." Covington's newest partners and their backgrounds are as follows:
May 8, 2002
May 8, 2002 - WASHINGTON, NEW YORK, LONDON & SAN FRANCISCO - Covington & Burling has promoted seven attorneys to counsel positions effective April 1, 2002. The new counsel are Dennis B. Auerbach, Wendy L. Feng, Marie A. Lavalleye, John B. Maclay, Lucinda Osborne, Lisa Peets and Elaine W. Stone.
Mr. Auerbach is Of Counsel in the Washington office. His ...
May 18, 1998, Covington Alert
By clicking on filters, the website automatically displays information related to specific interests.
Example: To find Covington’s representative matters, news, and insights related to product liability and mass tort defense class actions, take the following steps: